↓ Skip to main content

Dove Medical Press

Article Metrics

A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
18 Mendeley
Title
A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia
Published in
Neuropsychiatric Disease and Treatment, August 2013
DOI 10.2147/ndt.s50754
Pubmed ID
Authors

Hidenobu Suzuki, Keishi Gen

Abstract

There have not been any reports in Japan clarifying the efficacy and safety of intramuscular (IM) olanzapine and IM levomepromazine in agitated elderly patients with schizophrenia. This study was a comparative investigation of the clinical efficacy and safety of IM olanzapine and IM levomepromazine in agitated elderly patients with schizophrenia at 2 hours post-dose.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 11%
Student > Doctoral Student 2 11%
Student > Bachelor 2 11%
Researcher 2 11%
Student > Master 2 11%
Other 3 17%
Unknown 5 28%
Readers by discipline Count As %
Medicine and Dentistry 5 28%
Psychology 4 22%
Environmental Science 1 6%
Nursing and Health Professions 1 6%
Engineering 1 6%
Other 0 0%
Unknown 6 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2013.
All research outputs
#8,769,865
of 14,535,828 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,324
of 2,442 outputs
Outputs of similar age
#81,337
of 161,432 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#45
of 70 outputs
Altmetric has tracked 14,535,828 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,442 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,432 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.